Method and apparatus for ultrasonically increasing the transportation of therapeutic substances through tissue

• US 20060058708A1
• Filed: 05/31/2005
• Published: 03/16/2006
• Est. Priority Date: 12/24/2003
• Status: Abandoned Application

• Current Assignee: Cytodome, Inc.
• Original Assignee: Cytodome, Inc.
• Inventors: Brisken, Axel, Heart, Gill, Tolkowsky, Gideon
• Application Number:
  US11/140,845
• Publication Number:
  US 20060058708A1
• Time in Patent Office: Days
• US Class Current: 601/2
• CPC Class Codes: A61H 2201/105 with means for delivering media, e.g. drugs or cosmetics
• CPC Class Codes: A61H 23/0245 with ultrasonic transducers, e.g. piezoelectric
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis

Abstract

The transportation of therapeutic substances through internal tissue is enhanced by surgically implanting an ultrasound transducer in immediate proximity to the target tissue and oriented to direct ultrasound having selected characteristics toward the target tissue. The parameters of frequency, mechanical index, pulses per cycle and pulse repetition frequency are selected within defined ranges to cause molecules to be transported at a rate and over a distance substantially greater than by natural diffusion.

Claims

1. A method for enhancing the local delivery of therapeutic molecules to internal target tissue of a patient comprising:

delivering the molecules to the region of the target tissue;

generating an unfocused ultrasound field from a source located within the internal tissue and in the immediate vicinity of the target tissue to direct emitted ultrasound energy toward the target tissue, the ultrasound being characterized by a frequency in the range of about 500 kHz to about 1,500 kHz, a mechanical index of between about 0.5 and about 3.0, the ultrasound being pulsed and having between about 5 to about 20 cycles per pulse and a pulse repetition frequency of between about 100 to about 10,000 Hz;

the characteristics of the ultrasound energy being selected to enhance the transport of therapeutic molecules through the tissue under the influence of ultrasound energy at a rate substantially greater than the natural rate of transportation through the tissue, and in a sufficient number and concentration to have a therapeutic effect on the target tissue.

2. A method as defined in claim 1 wherein the thermal effect of the ultrasound is such that the target tissue is not raised more than about 2°

C.

3. A method as defined in claim 1 wherein the therapeutic molecules are transported over a distance of at least twenty millimeters.

4. A method as defined in claim 1 wherein the therapeutic molecules are transported over a distance of at least thirty millimeters.

5. A method as defined in claim 1 wherein the internal target tissue comprises brain tissue.

6. A method as defined in claim 1 wherein the tissue comprises soft tissue.

7. An apparatus for enhancing the local delivery of therapeutic molecules to internal target tissue of a patient comprising:

an implantable ultrasound transducer having an ultrasound emitting material with a surface area of sufficient dimensions to enable emission of energy having a frequency in the range of about 500 kHz to about 1,500 kHz, a mechanical index of about 0.5 to about 3.0, a thermal index no greater than about 2.0 with the pulses of ultrasound energy having between about 5 to about 20 cycles per pulse and a pulse repetition frequency of between 100 to about 10,000 Hz;

the ultrasound transducer being adapted to be implanted in immediate proximity to the target tissue.

8. An apparatus as defined in claim 7 further comprising the transducer having a maximum cross-sectional dimension not greater than about three centimeters.

9. An apparatus as defined in claim 7 wherein the transducer has a maximum cross-sectional dimension no greater than about two centimeters.